Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Long-Term Safety and Efficacy of Retigabine in Adult Epilepsy (Extension Study)
NCT00310388Phase 3Terminated
- Sponsor
- GSK
- Start
- Jul 2006
- Primary completion
- Apr 2017
- Modality
- Small Molecules
- Countries
- 12
01
Overview
A Phase 3 trial of retigabine in epilepsy, sponsored by GSK. Started Jul 2006; status: terminated.
02
Drugs
retigabine
03
Conditions
epilepsy
Beyond the preview
Go deeper on NCT00310388.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00310388.